Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
W Sun, R Liu, X Gao, Z Lin, H Tang, H Cui, E Zhao - Biomarker Research, 2023 - Springer
The serine-glycine-one-carbon (SGOC) metabolic pathway is critical for DNA methylation,
histone methylation, and redox homeostasis, in addition to protein, lipid, and nucleotide …
histone methylation, and redox homeostasis, in addition to protein, lipid, and nucleotide …
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
X Zhou, C Tian, Y Cao, M Zhao, K Wang - Frontiers in genetics, 2023 - frontiersin.org
Metabolic reprogramming is an important hallmark of malignant tumors. Serine is a non-
essential amino acid involved in cell proliferation. Serine metabolism, especially the de novo …
essential amino acid involved in cell proliferation. Serine metabolism, especially the de novo …
[HTML][HTML] SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer
SY Xie, DB Shi, Y Ouyang, F Lin, XY Chen… - American journal of …, 2022 - ncbi.nlm.nih.gov
Cancer cells modulate their metabolic activities to adapt to their growth and proliferation.
Despite advances in breast cancer biology having led to the widespread use of molecular …
Despite advances in breast cancer biology having led to the widespread use of molecular …
Systematic analysis and validation of the prognosis, immunological role and biology function of the ferroptosis-related lncRNA GSEC/miRNA-101-3p/CISD1 axis in …
X Jiang, Y Yuan, L Tang, J Wang, D Zhang… - Frontiers in Molecular …, 2022 - frontiersin.org
Lung adenocarcinoma (LUAD) is the most common type of lung cancer, accounting for
approximately 85% of pulmonary malignancies. Emerging evidence has demonstrated that …
approximately 85% of pulmonary malignancies. Emerging evidence has demonstrated that …
Uncovering SIRT3 and SHMT2-dependent pathways as novel targets for apigenin in modulating colorectal cancer: In vitro and in vivo studies
NM Abdelmaksoud, AI Abulsoud… - Experimental Cell …, 2024 - Elsevier
Despite significant advances in the treatment of colorectal cancer (CRC), identification of
novel targets and treatment options are imperative for improving its prognosis and survival …
novel targets and treatment options are imperative for improving its prognosis and survival …
[HTML][HTML] SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT
FC Huo, M Xie, ZM Zhu, JN Zheng, DS Pei - Genomics, 2022 - Elsevier
Abstract Objective Serine hydroxymethyltransferase 2 (SHMT2) is the first rate-limiting
enzyme for serine/glycine biosynthesis and one carbon metabolism. Here, we explore the …
enzyme for serine/glycine biosynthesis and one carbon metabolism. Here, we explore the …
Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy
W Sun, E Zhao, H Cui - International Journal of Cancer, 2023 - Wiley Online Library
Cancer cells selectively take up exogenous serine or synthesize serine via the serine
synthesis pathway for conversion into intracellular glycine and one‐carbon units for …
synthesis pathway for conversion into intracellular glycine and one‐carbon units for …
SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling
M Sun, M Zhao, R Li, Y Zhang, X Shi, C Ding… - Cell Death & …, 2024 - nature.com
Cancer cells alter their metabolism and epigenetics to support cancer progression.
However, very few modulators connecting metabolism and epigenetics have been …
However, very few modulators connecting metabolism and epigenetics have been …
Targeting one‐carbon metabolism for cancer immunotherapy
X Ren, X Wang, G Zheng, S Wang… - Clinical and …, 2024 - Wiley Online Library
Abstract Background One‐carbon (1C) metabolism is a metabolic network that plays
essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to …
essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to …
[PDF][PDF] 胰腺癌肝转移核心基因的筛选与验证
黄坤, 何运胜, 李建波, 赵攀, 肖春波, 赵平武 - 中国普通外科杂志, 2023 - zpwz.net
摘要背景与目的: 胰腺癌是预后极差的恶性肿瘤, 其5 年生存率约为11.5%, 有将近半数的患者在
初诊时已出现远处转移, 而肝转移则占到其中的37.0%~ 41.9%. 探索新的胰腺癌肝转移的生物 …
初诊时已出现远处转移, 而肝转移则占到其中的37.0%~ 41.9%. 探索新的胰腺癌肝转移的生物 …